Veterinary Medicines Information website

Nobilis Salenvac ETC suspension for injection for chickens

Authorised
  • Salmonella enterica, subsp. enterica, serovar Enteritidis, strain PT4, Inactivated
  • Salmonella enterica, subsp. enterica, serovar Infantis, strain A S03499-06, Inactivated
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, strain DT104, Inactivated
Download as PDF

Product identification

Medicine name:
Nobilis Salenvac ETC suspension for injection for chickens
Active substance:
  • Salmonella enterica, subsp. enterica, serovar Enteritidis, strain PT4, Inactivated
  • Salmonella enterica, subsp. enterica, serovar Infantis, strain A S03499-06, Inactivated
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, strain DT104, Inactivated
Target species:
  • Chicken
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Salmonella enterica, subsp. enterica, serovar Enteritidis, strain PT4, Inactivated
    1.00
    relative potency
    /
    0.50
    millilitre(s)
  • Salmonella enterica, subsp. enterica, serovar Infantis, strain A S03499-06, Inactivated
    1.00
    relative potency
    /
    0.50
    millilitre(s)
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, strain DT104, Inactivated
    1.00
    relative potency
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Low density polyethylene bottle containing 1000 doses of vaccine (each dose = 0.5 ml)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V557617
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0305/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 9/12/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 8/07/2026
Download
Dutch (PDF)
Published on: 8/07/2026
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 8/07/2026
Download
German (PDF)
Published on: 8/07/2026
Download
Dutch (PDF)
Published on: 8/07/2026
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 8/07/2026
Download
German (PDF)
Published on: 8/07/2026
Download
Dutch (PDF)
Published on: 8/07/2026
Download